Sage Therapeutics to Participate in Upcoming May Investor Conferences

Rhea-AI Summary

Sage Therapeutics, a biopharmaceutical company, will participate in investor conferences in May, including the 2024 RBCCM Global Healthcare Conference and BofA Securities 2024 Health Care Conference. The Company aims to create a world with better brain health. Live webcasts and replays of the presentations will be available on Sage's Investor page.

Positive

• Sage Therapeutics showcasing its presence and commitment in the healthcare industry by participating in prestigious investor conferences

Negative

• None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:

• 2024 RBCCM Global Healthcare Conference (New York, NY): fireside chat on Tuesday, May 14, 2024 at 11:30 a.m. ET.
• BofA Securities 2024 Health Care Conference (Las Vegas, NV): fireside chat on Wednesday, May 15, 2024 at 10:00 a.m. PT.

A live webcast of each presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the presentation and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507629601/en/

Investor

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com

Media

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics

FAQ

What upcoming investor conferences will Sage Therapeutics participate in May 2024?

Sage Therapeutics will participate in the 2024 RBCCM Global Healthcare Conference and BofA Securities 2024 Health Care Conference.

What is the focus of Sage Therapeutics?

Sage Therapeutics aims to create a world with better brain health.

Where can investors access the live webcasts of the presentations?

Investors can access the live webcasts on Sage's Investor page at investor.sagerx.com.

For how long will the webcast replays be available?

The webcast replays will be available for up to 30 days following the completion of the presentation.